Best in Biotech 18 Dec 2017 Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017 …widespread clotting and organ damage. Caplacizumab significantly reduced the time to platelet count response and achieved a 74% reduction in the relative risk of thromboembolic events and death and a… December 18, 2017 - 9 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 17 Jan 2024 Bladder cancer treatment: where are we standing? …patients experienced grade ≥3 adverse events which refers to severe and significant medical events. In this case, the most common adverse event observed were ash maculo-papular, hyperglycemia, neutropenia, peripheral sensory… January 17, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 25 Sep 2019 Danish Smallpox Vaccine Gets FDA Approval to Fight Bioterrorism …in case the disease is released again. However, the traditional smallpox vaccine uses viral vectors that can replicate in the body. This risks adverse events such as necrosis and infection,… September 25, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 7 Dec 2023 BIO-Europe 2023: top ten highlights The biopharma community met at Munich in Germany for BIO-Europe 2023, where attendees from across the world took part in networking events to foster collaboration, last month. With a turnout… December 7, 2023 - 24 minutesmins - By Dylan Kissane Share WhatsApp Twitter Linkedin Email
In Depth 9 May 2024 BTK inhibitors: can these drugs tackle cancer and autoimmunity? …after a phase 2 trial witnessed two deaths that included a fatal case of bleeding in the brain and adverse events like atrial fibrillation – a condition that causes the… May 9, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Oct 2018 The 7 Best Biotech Startup Competitions in Europe If you are looking for an opportunity to pitch your startup, look no further. Here’s a guide to the key European events for biotech startup competitions. Taking part in a… October 15, 2018 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2022 The challenges of translating CRISPR to the clinic …concerns, there are now a swathe of computational tools and assays available to assess and quantify these events. Indeed, in March this year the FDA released draft guidance on the… October 17, 2022 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 26 May 2023 Rocket Pharmaceuticals receives FDA designation for pyruvate kinase deficiency gene therapy …transfusion independence and improved quality of life with documented improvements via formal quality of life assessments. The safety profile appears favorable, with no RP-L301-related serious adverse events in either of… May 26, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Feb 2024 Biotechs in the US Capital: seven key players based in Washington DC …is significant as it recognizes LifeGel for its unique no-swelling property, crucial for reducing adverse events like nerve damage and paralysis in surgeries, particularly in the spine and cardiothoracic procedures…. February 20, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 18 Nov 2019 Update: Single-Shot Vaccine for Chikungunya Lasts for a Year in Phase I …showed no adverse events related to the vaccine, and continued to have antibodies against the virus in their blood. A group of the volunteers was injected with the vaccine for… November 18, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Jun 2025 Six kidney disease companies you should know about in 2025 …mg, and all treatment-related adverse events were reported as mild, with no severe or serious adverse events occurring. Maze also has another candidate in development, called MZE782, for the treatment… June 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 1 Aug 2024 European regulators reject Alzheimer’s drug Leqembi: is it downhill from here? …counterbalance the risk of serious adverse events associated with the medicine.” Table of contents Leqembi safety concerns threaten approval in Europe The pressing safety concern with the drug is a… August 1, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email